Transesophageal Echocardiology Measured Left Ventricular End Diastolic Area As Guide for Fluid Therapy in Major Oncosurgeries
TEE LVEDA
1 other identifier
interventional
60
1 country
1
Brief Summary
Intraoperative fluid management is pivotal to successful outcome of major oncosurgeries . Adequate volume replacement to achieve optimal cardiac performance is critical to prevent any deleterious consequences of under resuscitation or fluid overload . Traditionally CVP monitoring has been tool to guide intraoperative fluid therapy and has poor reliability as indicator of volume status . Transesophageal Echocardiography measured LVEDA is more reliable and sensitive measure of left ventricular volume to guide intraoperative fluid therapy . Investigators plan the study comparing total fluid requirement and postoperative outcomes in two groups of patients receiving central venous pressure (CVP) guided Conventional Fluid Therapy (CFT) and Left ventricular end diastolic area( LVEDA) guided fluids for major oncosurgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2019
CompletedFirst Submitted
Initial submission to the registry
February 8, 2019
CompletedFirst Posted
Study publicly available on registry
February 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2019
CompletedJanuary 22, 2025
January 1, 2025
4 months
February 8, 2019
January 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To calculate total intraoperative fluids required in TEE (study) and CVP (control) groups.
During the surgery Study group will receive fluids ( crystalloids and bolus colloids) guided by LVEDA cm2 and Control group will receive fluids (crystalloids and bolus colloids) guided by CVP cms H20
Upto 8 hours
Secondary Outcomes (3)
To compare serum lactate levels in millimols/litre
upto 48 hours
To compare serum creatinine in milligrams per decilitre in both the groups
Upto 48 hours.
Length of ICU stay
Upto 10 days
Study Arms (2)
LVEDA guided intraoperative fluid therapy
ACTIVE COMPARATORPatients in TEE group will be given crystalloid fluids during surgery guided by LVEDA cm2 to be maintained between 10 -18 cm2 , if LVEDA \< 10 cm2 then 200ml colloid bolus will be given and increase in LVEDA noted.
CVP guided intraoperative fluid therapy
ACTIVE COMPARATORPatients in CVP group will be given crystalloid fluids during surgery guided by CVP values to be maintained between 10 -16 cms of water H2O ,if CVP value \< 10 cms H2O then 200 ml colloid bolus will be given and increase in CVP value noted.
Interventions
Placement of Transoesophageal echocardiography probe in TEE group to measure Left ventricular end diastolic area cm2
Ultrasound guided Internal Jugular Vein catheter placement in CVP group to measure CVP value cms H2O .
Eligibility Criteria
You may qualify if:
- Patients undergoing major abdominopelvic oncosurgeries .
You may not qualify if:
- oesophageal varices
- carcinoma oesophagus
- carcinoma stomach
- coagulopathies
- duration of surgery exceeding 8 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anita Kulkarni
Delhi, National Capital Territory of Delhi, 110085, India
Related Publications (3)
Gutierrez MC, Moore PG, Liu H. Goal-directed therapy in intraoperative fluid and hemodynamic management. J Biomed Res. 2013 Sep;27(5):357-65. doi: 10.7555/JBR.27.20120128. Epub 2013 Mar 10.
PMID: 24086168BACKGROUNDCheung AT, Savino JS, Weiss SJ, Aukburg SJ, Berlin JA. Echocardiographic and hemodynamic indexes of left ventricular preload in patients with normal and abnormal ventricular function. Anesthesiology. 1994 Aug;81(2):376-87. doi: 10.1097/00000542-199408000-00016.
PMID: 8053588BACKGROUNDMarik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013 Jul;41(7):1774-81. doi: 10.1097/CCM.0b013e31828a25fd.
PMID: 23774337BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anita Kulkarni, MD
Rajiv Gandhi Cancer Institute & Research Centre , India
- PRINCIPAL INVESTIGATOR
Anita Kulkarni, M.D.
Rajiv Gandhi Cancer Institute & Research Centre , India
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients will be randomly allotted to either TEE or CVP Group according to computer generated randomization thus will be masked .
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 8, 2019
First Posted
February 25, 2019
Study Start
January 6, 2019
Primary Completion
April 30, 2019
Study Completion
May 10, 2019
Last Updated
January 22, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share